Design Therapeutics, Inc. (DSGN): 10-Q filed Nov 4, 2026

Form type

10-Q

Filing date

Nov 4, 2026

Accession number

0001193125-26-447258

Filer

Design Therapeutics, Inc. (CIK 1807120)